TWD 51.5
(-2.83%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 7.67 Million TWD | -60.57% |
2022 | 19.45 Million TWD | 241.44% |
2021 | 5.69 Million TWD | 2.87% |
2020 | 5.53 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 7.3 Million TWD | 0.0% |
2024 Q2 | 31.15 Million TWD | 0.0% |
2023 Q3 | 9.29 Million TWD | -11.25% |
2023 FY | 7.67 Million TWD | -60.57% |
2023 Q1 | - TWD | -100.0% |
2023 Q2 | 10.47 Million TWD | 0.0% |
2023 Q4 | 7.67 Million TWD | -17.45% |
2022 Q4 | 19.45 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | 89.349% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | 89.926% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | 97.679% |
TTY Biopharm Company Limited | 403.04 Million TWD | 98.097% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 99.474% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 99.652% |
Center Laboratories, Inc. | 4.42 Billion TWD | 99.827% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -1934.748% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | 97.63% |
InnoPharmax Inc. | 5.38 Million TWD | -42.425% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | 92.392% |
Excelsior Biopharma Inc. | 300.25 Million TWD | 97.445% |
DV Biomed Co., Ltd. | 315.74 Million TWD | 97.571% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | 41.51% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | 98.465% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -5458.696% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | 86.316% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | 81.59% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | 88.316% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |